Tempest Therapeutics, Inc. (TPST)
2.43
+0.06
(+2.53%)
USD |
NASDAQ |
Feb 19, 16:00
2.38
-0.05
(-2.06%)
After-Hours: 07:40
Tempest Therapeutics Shareholders Equity (Quarterly) : 6.346M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Agenus, Inc. | -274.14M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
| Arrowhead Pharmaceuticals, Inc. | 568.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.13M |
| Total Liabilities (Quarterly) | 10.78M |
| Debt to Equity Ratio | 1.324 |
| Current Ratio | 2.299 |
| Net Debt Paydown Yield | 6.26% |